Additionally, it should not be used if a patient has an ongoing gallbladder inflammation, severe pain or burning sensation in the stomach area, difficulty breathing, poor gastrointestinal tolerability to semaglutide (the main active ingredient of Wegovy), severe nausea, and other symptoms occurring in response to GLP 1 receptor agonists
Some protein blends are even better since they each digest at different rates
So by far, these injectables are the most appropriate for people who have heart disease or polypharmacy, meaning they take a long list of medications
For FDA-approved uses, semaglutide is meant to be taken in specific, clinically tested, weekly dosages, not in daily micro-doses
Most patients begin noticing appetite changes and improved energy within the first 12 weeks